Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-110108
Filing Date
2018-04-06
Accepted
2018-04-06 16:51:40
Documents
89
Period of Report
2018-01-17
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d521123d8ka.htm 8-K/A 18480
2 EX-99.1 d521123dex991.htm EX-99.1 470824
3 EX-99.2 d521123dex992.htm EX-99.2 110488
  Complete submission text file 0001193125-18-110108.txt   5842313

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT evfm-20171231.xml EX-101.INS 1061072
5 XBRL TAXONOMY EXTENSION SCHEMA evfm-20171231.xsd EX-101.SCH 67298
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evfm-20171231_cal.xml EX-101.CAL 92195
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evfm-20171231_def.xml EX-101.DEF 286528
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE evfm-20171231_lab.xml EX-101.LAB 583602
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evfm-20171231_pre.xml EX-101.PRE 471164
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

EIN.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36754 | Film No.: 18743744
SIC: 2834 Pharmaceutical Preparations